Announcements Trials
Browse Landscape

Status

Terminated 1

Sponsor Class

OTHER 289INDUSTRY 65OTHER_GOV 15NIH 15NETWORK 1INDIV 1

Study Type

Interventional 46Observational 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Leukemia 81Breast Neoplasms 52Precursor Cell Lymphoblastic Leukemia-Lymphoma 41Lymphoma 40Leukemia, Myeloid, Acute 33Neoplasms 29Colorectal Neoplasms 26Sarcoma 24Congenital Abnormalities 24Lung Neoplasms 20Carcinoma, Non-Small-Cell Lung 20Prostatic Neoplasms 19Neuroblastoma 19Ovarian Neoplasms 17Rectal Neoplasms 15Osteosarcoma 15Leukemia, Lymphocytic, Chronic, B-Cell 15Colonic Neoplasms 15Wilms Tumor 14Melanoma 14Multiple Myeloma 13Lymphoma, Follicular 13Leukemia, Myelomonocytic, Acute 13Leukemia, Megakaryoblastic, Acute 13Kidney Neoplasms 13Leukemia, Monocytic, Acute 12Leukemia, Erythroblastic, Acute 12HIV Infections 12Central Nervous System Neoplasms 12Lymphoma, Non-Hodgkin 11

Interventions

Urination 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Observational × Urinary Bladder Neoplasms × Clear all
NCT02538809 2025-02-13

Novel mRNA-based Urine Test for Bladder Cancer in Spinal Cord Injury Individuals

Swiss Paraplegic Research, Nottwil

Terminated
50 enrolled
Genitourinary

Urinary Bladder Neoplasms, Spinal Cord Injuries

Data powered by HemOnc (CC BY 4.0) Colophon âš¡